Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt 0.01
HCP's Cash to Debt is ranked lower than
57% of the 595 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 0.06 vs. HCP: 0.01 )
HCP' s 10-Year Cash to Debt Range
Min: 0   Max: 0.52
Current: 0.01

0
0.52
Equity to Asset 0.54
HCP's Equity to Asset is ranked higher than
78% of the 632 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 0.48 vs. HCP: 0.54 )
HCP' s 10-Year Equity to Asset Range
Min: 0.31   Max: 0.6
Current: 0.54

0.31
0.6
Interest Coverage 1.92
HCP's Interest Coverage is ranked higher than
69% of the 508 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 2.14 vs. HCP: 1.92 )
HCP' s 10-Year Interest Coverage Range
Min: 0.31   Max: 3.12
Current: 1.92

0.31
3.12
F-Score: 7
Z-Score: 1.40
M-Score: 7.05
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 39.71
HCP's Operating margin (%) is ranked higher than
71% of the 630 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 40.21 vs. HCP: 39.71 )
HCP' s 10-Year Operating margin (%) Range
Min: 7.99   Max: 57.14
Current: 39.71

7.99
57.14
Net-margin (%) 46.23
HCP's Net-margin (%) is ranked higher than
78% of the 631 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 35.06 vs. HCP: 46.23 )
HCP' s 10-Year Net-margin (%) Range
Min: 11.46   Max: 78.06
Current: 46.23

11.46
78.06
ROE (%) 9.05
HCP's ROE (%) is ranked higher than
83% of the 631 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 6.52 vs. HCP: 9.05 )
HCP' s 10-Year ROE (%) Range
Min: 2.28   Max: 23.65
Current: 9.05

2.28
23.65
ROA (%) 4.84
HCP's ROA (%) is ranked higher than
83% of the 634 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 3.12 vs. HCP: 4.84 )
HCP' s 10-Year ROA (%) Range
Min: 1.08   Max: 12.02
Current: 4.84

1.08
12.02
ROC (Joel Greenblatt) (%) 7.81
HCP's ROC (Joel Greenblatt) (%) is ranked higher than
77% of the 541 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 5.16 vs. HCP: 7.81 )
HCP' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 0.78   Max: 11.44
Current: 7.81

0.78
11.44
Revenue Growth (%) 4.50
HCP's Revenue Growth (%) is ranked higher than
84% of the 529 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: -0.20 vs. HCP: 4.50 )
HCP' s 10-Year Revenue Growth (%) Range
Min: -11.6   Max: 24.3
Current: 4.5

-11.6
24.3
EBITDA Growth (%) 5.60
HCP's EBITDA Growth (%) is ranked higher than
77% of the 484 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 3.00 vs. HCP: 5.60 )
HCP' s 10-Year EBITDA Growth (%) Range
Min: -29.1   Max: 69.6
Current: 5.6

-29.1
69.6
EPS Growth (%) 29.40
HCP's EPS Growth (%) is ranked higher than
92% of the 391 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: -1.20 vs. HCP: 29.40 )
HCP' s 10-Year EPS Growth (%) Range
Min: -26.2   Max: 98.5
Current: 29.4

-26.2
98.5
» HCP's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2013

HCP Guru Trades in Q3 2013

Chris Davis 217,062 sh (New)
Steven Cohen 19,037 sh (+78.27%)
Manning & Napier Advisors, Inc 288,113 sh (+30.46%)
Steven Romick -226,700 sh (unchged)
Ray Dalio Sold Out
Jeremy Grantham 120,485 sh (-8.02%)
Pioneer Investments 522,690 sh (-18.56%)
Jim Simons 997,400 sh (-33.39%)
» More
Q4 2013

HCP Guru Trades in Q4 2013

Paul Tudor Jones 8,616 sh (New)
Jim Simons 1,240,900 sh (+24.41%)
Chris Davis 236,174 sh (+8.8%)
Manning & Napier Advisors, Inc 296,913 sh (+3.05%)
Jeremy Grantham 121,157 sh (+0.56%)
Steven Romick -226,700 sh (unchged)
Louis Moore Bacon 300,000 sh (unchged)
Steven Cohen Sold Out
Pioneer Investments 490,203 sh (-6.22%)
» More
Q1 2014

HCP Guru Trades in Q1 2014

Steven Cohen 20,792 sh (New)
Paul Tudor Jones 9,899 sh (+14.89%)
Manning & Napier Advisors, Inc 312,123 sh (+5.12%)
Pioneer Investments 501,420 sh (+2.29%)
Steven Romick -226,700 sh (unchged)
Louis Moore Bacon 100,000 sh (unchged)
Chris Davis Sold Out
Jeremy Grantham 98,000 sh (-19.11%)
Jim Simons 831,103 sh (-33.02%)
» More
Q2 2014

HCP Guru Trades in Q2 2014

Steven Romick -226,700 sh (unchged)
Manning & Napier Advisors, Inc 258,030 sh (-17.33%)
» More
» Details

Insider Trades

Latest Guru Trades with HCP

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Ray Dalio 2013-09-30 Sold Out 0.01%$39.39 - $47.28 $ 42.630%0
Ray Dalio 2013-06-30 New Buy0.01%$41.89 - $55.28 $ 42.63-15%13000
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 19.60
HCP's P/E(ttm) is ranked higher than
79% of the 690 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 27.50 vs. HCP: 19.60 )
HCP' s 10-Year P/E(ttm) Range
Min: 7.86   Max: 82.49
Current: 19.6

7.86
82.49
P/B 1.80
HCP's P/B is ranked higher than
60% of the 690 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 1.29 vs. HCP: 1.80 )
HCP' s 10-Year P/B Range
Min: 0.84   Max: 5.1
Current: 1.8

0.84
5.1
P/S 9.20
HCP's P/S is ranked higher than
61% of the 690 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 7.70 vs. HCP: 9.20 )
HCP' s 10-Year P/S Range
Min: 3.36   Max: 14.33
Current: 9.2

3.36
14.33
PFCF 20.60
HCP's PFCF is ranked higher than
81% of the 690 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 158.88 vs. HCP: 20.60 )
HCP' s 10-Year PFCF Range
Min: 10.72   Max: 480
Current: 20.6

10.72
480
EV-to-EBIT 32.87
HCP's EV-to-EBIT is ranked higher than
73% of the 690 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 35.26 vs. HCP: 32.87 )
HCP' s 10-Year EV-to-EBIT Range
Min: 17.8   Max: 390.9
Current: 32.87

17.8
390.9
PEG 2.30
HCP's PEG is ranked higher than
88% of the 690 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 9999.00 vs. HCP: 2.30 )
HCP' s 10-Year PEG Range
Min: 1.03   Max: 1201.22
Current: 2.3

1.03
1201.22
Shiller P/E 27.60
HCP's Shiller P/E is ranked higher than
90% of the 690 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 9999.00 vs. HCP: 27.60 )
HCP' s 10-Year Shiller P/E Range
Min: 9.03   Max: 34.42
Current: 27.6

9.03
34.42
Current Ratio 1.39
HCP's Current Ratio is ranked higher than
81% of the 575 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 0.87 vs. HCP: 1.39 )
HCP' s 10-Year Current Ratio Range
Min: 0.3   Max: 10.36
Current: 1.39

0.3
10.36
Quick Ratio 1.39
HCP's Quick Ratio is ranked higher than
83% of the 575 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 0.82 vs. HCP: 1.39 )
HCP' s 10-Year Quick Ratio Range
Min: 0.3   Max: 10.36
Current: 1.39

0.3
10.36

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 5.00
HCP's Dividend Yield is ranked higher than
62% of the 632 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 4.25 vs. HCP: 5.00 )
HCP' s 10-Year Dividend Yield Range
Min: 3.72   Max: 11.35
Current: 5

3.72
11.35
Dividend Payout 1.07
HCP's Dividend Payout is ranked higher than
80% of the 690 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 1.87 vs. HCP: 1.07 )
HCP' s 10-Year Dividend Payout Range
Min: 0.29   Max: 9.3
Current: 1.07

0.29
9.3
Dividend growth (3y) 4.10
HCP's Dividend growth (3y) is ranked higher than
69% of the 401 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 6.30 vs. HCP: 4.10 )
HCP' s 10-Year Dividend growth (3y) Range
Min: -6.8   Max: 12.4
Current: 4.1

-6.8
12.4
Yield on cost (5-Year) 5.91
HCP's Yield on cost (5-Year) is ranked higher than
64% of the 617 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 4.48 vs. HCP: 5.91 )
HCP' s 10-Year Yield on cost (5-Year) Range
Min: 4.4   Max: 13.42
Current: 5.91

4.4
13.42
Share Buyback Rate -14.10
HCP's Share Buyback Rate is ranked higher than
63% of the 507 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: -7.00 vs. HCP: -14.10 )
HCP' s 10-Year Share Buyback Rate Range
Min: -2.7   Max: -22.7
Current: -14.1

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 1.90
HCP's Price/Tangible Book is ranked higher than
62% of the 690 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 1.34 vs. HCP: 1.90 )
HCP' s 10-Year Price/Tangible Book Range
Min: 1.04   Max: 4.81
Current: 1.9

1.04
4.81
Price/DCF (Projected) 1.40
HCP's Price/DCF (Projected) is ranked higher than
88% of the 690 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 54.08 vs. HCP: 1.40 )
HCP' s 10-Year Price/DCF (Projected) Range
Min: 0.93   Max: 33.16
Current: 1.4

0.93
33.16
Price/Median PS Value 1.00
HCP's Price/Median PS Value is ranked higher than
87% of the 690 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 1.23 vs. HCP: 1.00 )
HCP' s 10-Year Price/Median PS Value Range
Min: 0.41   Max: 1.54
Current: 1

0.41
1.54
Price/Peter Lynch Fair Value 3.20
HCP's Price/Peter Lynch Fair Value is ranked higher than
91% of the 690 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 9999.00 vs. HCP: 3.20 )
HCP' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.62   Max: 19.98
Current: 3.2

0.62
19.98
Price/Graham Number 1.30
HCP's Price/Graham Number is ranked higher than
74% of the 690 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 1.48 vs. HCP: 1.30 )
HCP' s 10-Year Price/Graham Number Range
Min: 0.63   Max: 2.6
Current: 1.3

0.63
2.6
Earnings Yield (Greenblatt) 3.00
HCP's Earnings Yield (Greenblatt) is ranked higher than
67% of the 615 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 3.50 vs. HCP: 3.00 )
HCP' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.3   Max: 5.6
Current: 3

0.3
5.6
Forward Rate of Return (Yacktman) 9.51
HCP's Forward Rate of Return (Yacktman) is ranked higher than
85% of the 517 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 2.16 vs. HCP: 9.51 )
HCP' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -2.5   Max: 22.4
Current: 9.51

-2.5
22.4

Business Description

Industry: REITs » REIT - Healthcare Facilities
Compare:HTA, VTR, LTC, OHI, HR » details
Traded in other countries:HC5.Germany
HCP, Inc. a self-administered, Maryland real estate investment trust, was organized in 1985. It invests mainly in real estate serving the healthcare industry in the United States. The Company acquires, develops leases, manages and disposes of healthcare real estate, and provides financing to healthcare providers. Its portfolio is comprised of investments in the following five healthcare segments: senior housing, life science, medical office, hospital and skilled nursing. It makes investments within its healthcare segments using the following five investment products: properties under lease, debt investments, developments and redevelopments, investment management and DownREITs. The Company has interests in 314 senior housing facilities, including 21 facilities owned by its Investment Management Platform. Senior housing facilities include independent living facilities, assisted living facilities and continuing care retirement communities, which cater to different segments of the elderly population based upon their needs. Services provided by the company's operators or tenants in these facilities are mainly paid for by the residents directly or through private insurance and are less reliant on government reimbursement programs such as Medicaid and Medicare. The Company has interests in 108 life science properties, including four facilities owned by its Investment Management Platform. These properties contain laboratory and office space mainly for biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other organizations involved in the life science industry. The Company has interests in 254 medical office buildings, including 66 facilities owned by its Investment Management Platform. These facilities typically contain physicians' offices and examination rooms, and might also include pharmacies, hospital ancillary service space and outpatient services such as diagnostic centers, rehabilitation clinics and day-surgery operating rooms. The Company has interests in 21 hospitals, including four facilities owned by its Investment Management Platform. Services provided by the Company's operators and tenants in these facilities are paid for by private sources, third-party payors, or through the Medicare and Medicaid programs. The Company has interests in 313 skilled nursing facilities. Skilled nursing facilities offer restorative, rehabilitative and custodial nursing care for people not requiring the sophisticated treatment available at hospitals. The Company faces competition from other REITs, investment companies, private equity and hedge fund investors, sovereign funds, healthcare operators, lenders, developers and other institutional investors, some of whom might have greater resources and lower costs of capital. The Company's tenants and operators are typically subject to complex federal, state and local healthcare laws and regulations relating to fraud and abuse practices, government reim
» More Articles for HCP

Headlines

Articles On GuruFocus.com
Four Businesses with Over 5% Dividend Yields & Over 25 Years of Dividend Increases Jul 19 2014 
6 Stocks Currently Trading Below Fair Value Jul 02 2014 
GuruFocus Names Four Dividend Growers May 05 2014 
HCP Inc. Dividend Safety Analysis - Income Investors Should Take Notice May 01 2014 
High-Yield, High-Risk Dividend Stocks Mar 19 2014 
GuruFocus Reports Nine Dividend Growers Feb 04 2014 
15 Stocks Using Cash to Pay Higher Dividends Feb 03 2014 
GuruFocus Weekly Dividend Growers Pt. I Oct 28 2013 
Guru Stocks at 52-Week Lows: RDS.A, AMT, HDB, RCI, HCP Aug 12 2013 
My 4 Favorite High-Beta Dividend Aristocrats Aug 07 2013 

More From Other Websites
Coverage initiated on HCP by Mizuho Jul 23 2014
Best Of The Buy-Rated Dividend Stocks: Top 3 Companies: RGP, HCP, VTR Jul 21 2014
A Good Week For HCP, Health Care REIT, Biomed Realty Jul 10 2014
HCP: Decidedly More Affordable After CEO Got Fired Jul 10 2014
4 Businesses With 5%+ Yields And 25+ Years Of Consecutive Dividend Increases Jul 09 2014
What To Buy: Top 3 Buy-Rated Dividend Stocks: HCP, MPW, KMI Jul 08 2014
HCP to Report Second Quarter 2014 Financial Results and Host Conference Call/Webcast Jul 08 2014
HCP to Report Second Quarter 2014 Financial Results and Host Conference Call/Webcast Jul 08 2014
A Wall Street Transcript Interview with Paul E. Adornato, CFA, a Senior Analyst in BMO Capital... Jun 26 2014
Best 3 Yielding Buy-Rated Stocks: LAMR, LHO, HCP Jun 24 2014
3 Stocks Moving The Real Estate Industry Upward Jun 23 2014
Simon Says, Health Care REIT Spinoff Might Be Next Jun 20 2014
Insider Trading Alert - LCI, HCP And NVAX Traded By Insiders Jun 19 2014
Top 3 Yielding Buy-Rated Stocks: RDS.B, HCP, VTR Jun 09 2014
Insider Trading Alert - CFN, ESV And HCP Traded By Insiders Jun 04 2014
Updated Research Report on HCP Jun 03 2014
The All-Aristocrat Team: Dividend Stocks You Can Trust In An Uncertain Market (Part 1) Jun 02 2014
3 Stocks Advancing The Real Estate Industry Jun 02 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide